TIAA CREF Investment Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $1.64M | Sell |
152,943
-12,359
| -7% | -$133K | ﹤0.01% | 2095 |
|
|
2018
Q4 | $2.5M | Sell |
165,302
-2,374
| -1% | -$35.8K | ﹤0.01% | 1825 |
|
|
2018
Q3 | $3.1M | Sell |
167,676
-73,252
| -30% | -$1.36M | ﹤0.01% | 1897 |
|
|
2018
Q2 | $5.51M | Buy |
240,928
+31,127
| +15% | +$712K | ﹤0.01% | 1529 |
|
|
2018
Q1 | $5.97M | Sell |
209,801
-2,246
| -1% | -$63.9K | ﹤0.01% | 1446 |
|
|
2017
Q4 | $4.48M | Sell |
212,047
-25,652
| -11% | -$541K | ﹤0.01% | 1675 |
|
|
2017
Q3 | $4.32M | Buy |
237,699
+68,147
| +40% | +$1.24M | ﹤0.01% | 1717 |
|
|
2017
Q2 | $2.63M | Buy |
169,552
+109,791
| +184% | +$1.7M | ﹤0.01% | 2019 |
|
|
2017
Q1 | $1.03M | Sell |
59,761
-6,141
| -9% | -$106K | ﹤0.01% | 2489 |
|
|
2016
Q4 | $724K | Sell |
65,902
-186
| -0.3% | -$2.04K | ﹤0.01% | 2686 |
|
|
2016
Q3 | $1.04K | Sell |
66,088
-280
| -0.4% | -$4 | ﹤0.01% | 2524 |
|
|
2016
Q2 | $678K | Buy |
66,368
+49,158
| +286% | +$502K | ﹤0.01% | 2725 |
|
|
2016
Q1 | $222K | Hold |
17,210
| – | – | ﹤0.01% | 2964 |
|
|
2015
Q4 | $359K | Buy |
+17,210
| New | +$359K | ﹤0.01% | 2981 |
|